Compare Amylx Pharmaceuticals Inc (AMLX) vs Hyatt Hotels Corporation (H) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Hyatt Hotels Corporation — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Hyatt Hotels Corporation trades at $172.22 (market cap $16.27B). The key difference: Hyatt Hotels Corporation is far larger — about 6.2× Amylx Pharmaceuticals Inc's market cap, and Hyatt Hotels Corporation pays a 0.35% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | H | |
|---|---|---|
Market Cap | $2.64B | $16.27B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $202.09 |
52-Week Low | $7.82 | $135.42 |
Enterprise Value | $2.39B | $20.17B |
Dividend Yield | — | 0.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Hyatt Hotels Corporation
Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.
Read more on H →
